Ishita Drugs & Industries Other Announcement
Ishita Drugs & Industries Ltd submitted its quarterly shareholding pattern under Regulation 31, disclosing the promoter and public shareholdings as of September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Ishita Drugs & Industries Ltd submitted its quarterly shareholding pattern under Regulation 31, disclosing the promoter and public shareholdings as of September 30, 2026.
Ishita Drugs & Industries Ltd has re-appointed M/s. Jaymin Shah & Associates as its Statutory Auditor from the 33rd to the 34th AGM.
Ishita Drugs & Industries Ltd has issued physical letters to shareholders with weblinks for its FY 2025-26 Annual Report. The 33rd AGM is scheduled for September 30, 2026.
Ishita Drugs & Industries Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.